A growing number of federal and state regulations ensure appropriate controls around electronic prescriptions for controlled substances. While substances listed on Schedules II-V can be prescribed for medical use, some states impose even more stringent requirements in addition to those set by the DEA. As such, hospitals, clinics and other organizations that electronically prescribe controlled substance confront challenges in providing these electronic prescriptions.
